Efficiency and safety of the modified protocol for cardioversion of atrial fibrillation using domestic antiarrhythmic drug Refralon. Initial clinical resultsKh.M. Dzaurova,N.Yu. Mironov,Yu.A. Yuricheva, V.V. Vlodzyanovsky, D.A. Gagloeva,L.Yu. Laiovich, T.A. Malkina, L.V. Zinchenko,S.F. Sokolov,S.P. GolitsynKardiologicheskii vestnik（2021）引用 1|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
